| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230556 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
A preoperative regimen of S-1, irinotecan, and radiotherapy to the rectum was feasible, and it appeared safe and effective in this nonrandomized Phase II setting. It exhibited a low incidence of adverse events, a high rate of completion of treatment, and an extremely high rate of pathologic complete response.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Takeo M.D., Heita M.D., Kazuhiko M.D., Wataru M.D., Masanori M.D., Takatoshi M.D., Atsushi M.D., Wasaburo M.D., Kazushige M.D., Isao M.D., Keishi M.D., Masahiko M.D.,